These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31850110)
1. Large B - Cell Lymphoma of the Leg - Unfavourable Course with Rituximab/Bendamustin. Wollina U; Schmidt N; Schönlebe J; Vojvodic A; Hansel G; Koch A; Lotti T Open Access Maced J Med Sci; 2019 Sep; 7(18):3006-3008. PubMed ID: 31850110 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of primary diffuse large B-cell lymphoma, leg type. Alcántara-González J; González-García C; Fernández-Guarino M; Jaén-Olasolo P Actas Dermosifiliogr; 2014; 105(1):78-83. PubMed ID: 23098572 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008 [TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875 [TBL] [Abstract][Full Text] [Related]
6. Bone involvement in two cases of thoracic primary cutaneous diffuse large B-cell lymphoma, leg type. Lipowicz S; Beylot-Barry M; Choquet S; Maksud P; Vergier B; Albertini AF; Frances C; Barete S Eur J Dermatol; 2011; 21(5):744-9. PubMed ID: 21700538 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas. Brandenburg A; Humme D; Terhorst D; Gellrich S; Sterry W; Beyer M Br J Dermatol; 2013 Nov; 169(5):1126-32. PubMed ID: 23796422 [TBL] [Abstract][Full Text] [Related]
8. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases. Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906 [TBL] [Abstract][Full Text] [Related]
9. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells. Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055 [TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences. Felcht M; Klemke CD; Nicolay JP; Weiss C; Assaf C; Wobser M; Schlaak M; Hillen U; Moritz R; Tantcheva-Poor I; Nashan D; Beyer M; Dippel E; Müller CSL; Sachse MM; Meiss F; Géraud C; Marx A; Goerdt S; Geissinger E; Kempf W J Dtsch Dermatol Ges; 2019 Mar; 17(3):275-285. PubMed ID: 30851152 [TBL] [Abstract][Full Text] [Related]
12. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis. Teichert M; Stumpf C; Booken N; Wobser M; Nashan D; Hallermann C; Mogler C; Müller CS; Becker JC; Moritz RK; Andrulis M; Nicolay JP; Goerdt S; Thomas M; Klemke CD; Augustin HG; Felcht M Exp Dermatol; 2015 Jun; 24(6):424-9. PubMed ID: 25776770 [TBL] [Abstract][Full Text] [Related]
13. CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule. Xiao A; Beatty CJ; Choudhary S; Akilov OE Hematol Rep; 2023 Sep; 15(3):513-517. PubMed ID: 37754668 [TBL] [Abstract][Full Text] [Related]
14. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Wilcox RA Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522 [TBL] [Abstract][Full Text] [Related]
16. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Bischin AM; Dorer R; Aboulafia DM Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851 [TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Servitje O; Gallardo F; Estrach T; Pujol RM; Blanco A; Fernández-Sevilla A; Pétriz L; Peyrí J; Romagosa V Br J Dermatol; 2002 Dec; 147(6):1147-58. PubMed ID: 12452864 [TBL] [Abstract][Full Text] [Related]